Abstract
Background and Hypothesis
Deviated brain folding patterns in psychosis may reflect dysfunctional brain development, more specifically cortical growth and white matter myelination. However, mechanisms that underlie the cortical folding disturbances and their relationship to clinical phenotypes in psychosis remain unknown.
Study Design
This cross-sectional multimodal neuroimaging study combines structural and diffusion magnetic resonance imaging (MRI) in 203 individuals with early psychosis and 73 healthy individuals. The primary goal is to use local gyrification index (LGI), which quantifies cortical folding, to assess possible cortical abnormalities in subjects with early psychosis. The secondary goal is to combine gyrification measures with advanced diffusion MRI indices, namely, heterogeneity of fractional anisotropy (FA), a proxy for cortical cytoarchitecture, and free-water corrected FA, the latter associated with the tissue-related white matter microstructure. Finally, the relationship between these imaging measures with psychiatric symptoms and cognitive abilities are examined.
Study Results
Compared to healthy individuals, the early psychosis group exhibited a significant LGI reduction, potentially reflecting sulcal widening and shallowing in the left temporo-parietal region. Local gyrification index was significantly associated with heterogeneity of FA in the corresponding region. Lower LGI was also associated with reduced FA in the white matter tracts connecting this region to the frontal lobe. Finally, lower LGI at the temporo-parietal junction was associated with more severe negative symptoms.
Conclusions
We present the first in vivo evidence that anomalies in cortical folding may be linked to alterations in both the underlying cortical cytoarchitecture and associated microstructure of ipsilateral long-range white matter connections in psychosis.
Keywords: local gyrification index, fractional anisotropy, tissue-specific fractional anisotropy, heterogeneity of fractional anisotropy, multimodal, early psychosis, magnetic resonance imaging
Introduction
Psychotic disorders, encompassing schizophrenia spectrum disorders and affective disorders with psychosis, represent psychiatric conditions characterized by hallucinations and delusions.1 Some individuals with psychotic disorders, especially schizophrenia spectrum disorders, also exhibit negative symptoms and cognitive impairments, potentially leading to generalized functional deterioration.2,3 Early-life brain disruptions may heighten vulnerability to psychosis, with subsequent aberrant brain maturation potentially precipitating its onset.4-6
During early brain development, the cortical surface folds into gyri and sulci thereafter continuously transforming its sulcal–gyral pattern.7,8 This process is guided by both local cortical growth and mechanical tension of the growing myelinated axons.9 The resulting gyrification pattern can be quantified using magnetic resonance imaging (MRI) and the gyrification index, a metric that quantifies the amount of cortex buried within the sulcal folds, relative to the amount of cortex on the exterior surface of the brain.10
To date, several MRI studies have reported anomalies in the gyrification pattern in psychotic disorders. One earlier study also showed sulco-gyral pattern anomalies in temporal lobe regions in individuals with chronic schizophrenia.11 While these findings are inconsistent, most studies report an increased complexity of brain folding (ie, increased gyrification index) particularly in frontal and temporal regions during early course of psychosis, including first-episode schizophrenia12,13 and at-risk mental state.14 Notably, there is a decreased complexity of brain folding (ie, decreased gyrification index) in later stages of the illness affecting several cortical regions (eg, medial parietal cortex).15-17 In this context, decreased gyrification index can be viewed as possibly reflecting concurrent sulcal widening and diminished sulcal depth.7
Cortical folding is guided during brain development by the growth and expansion of the cortical layers, including cell differentiation, migration, synapse formation, and the mechanical tension of axons that involves the pushing and pulling of the cortical ribbon by myelinating axonal bundles.18 Indeed, changes in neuronal size, neuronal density, and neuropil reductions are reported in vitro in schizophrenia,19 and are linked to cortical neurodevelopmental pathology.20 In addition, abnormalities in myelin-related genes21 and changes in the density of interstitial white matter neurons22 in post-mortem brains of individuals with schizophrenia support evidence for possible neurodevelopmental white matter pathology. However, there is limited evidence whether gyrification changes are aligned with cortical or white matter neurodevelopmental disorders, namely, disorganized cortical layers and poorly myelinated or coherent white matter tracts. Few multimodal studies have examined the association between LGI and conventional diffusion MRI metrics in psychiatric disorders,23-25 failing to demonstrate any association with fractional anisotropy (FA), a primary measure of white matter microstructure.
In the current multimodal neuroimaging study, we measure the local gyrification index (LGI), a measure of the degree of cortical folding which has a methodological advantage over other gyrification indices because it takes into account the inherent three-dimensional nature of the cortical surface26 in individuals with psychotic disorders. The LGI is calculated as the ratio of the surface area of the cerebral cortex, comprising folds and grooves to the surface area of a virtual smooth layer enveloping the cerebral cortex in the corresponding brain regions.26 We also examined the microstructure of both underlying gray matter and associated white matter connections in the same sample. For estimation of gray matter microstructure, we used heterogeneity of fractional anisotropy (HFA), which is sensitive to variation in the microstructural characteristics of gray matter tissue.27 To assess white matter microstructure, free-water corrected tractography was applied.28 We used structural and diffusion MRI scans from the Human Connectome Project for Early Psychosis (HCP-EP) dataset,29 which was collected using state-of-the-art HCP imaging protocols. Our aim in the current study was to explore the relationship between gyrification and cortical and white matter pathology in this population. This study represents the first to examine the relationship between LGI and advanced diffusion MRI indices derived from free-water imaging28 in psychiatric disorders. We hypothesized that altered LGI would be associated with disruptions in HFA27 and free-water corrected diffusivity indices,30 which serve, respectively, as in vivo indicators of cortical cytoarchitecture and white matter integrity in psychosis.
Methods
Below, we first describe the recruitment criteria and demographic characteristics of the participants, along with a description of the clinical symptoms and cognitive measures used in this study. Next, we outline the MRI acquisition and preprocessing steps, including the diffusion MRI harmonization. This is then followed by a description of the LGI calculation and the identification of the brain region of interest (ROI). The LGI calculation is performed using a surface-based analysis that evaluates LGI at each vertex across the cortical surface model. The brain region of interest consists of all vertices showing significant LGI differences between early psychosis and controls and will henceforth be referred to as the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex).
This is then followed by an explanation of the HFA measurements in the corresponding brain region and the extraction of free-water corrected diffusivity indices in the fiber tracts originating or terminating at the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex). The former served as an index of cortical cytoarchitecture, while the latter reflects white matter integrity. Finally, we describe the statistical methods employed to examine group difference in LGI, and we investigated the associations between LGI and HFA, as well as LGI and other diffusivity indices. Finally, we explored the associations of LGI, HFA, and diffusivity indices with clinical and cognitive variables. As noted previously, detailed information regarding the participants, assessments, and imaging procedures is published in the HCP-EP protocol paper,29 although some of the more detailed descriptions have been relocated to the Supplementary Materials.
Participants
The total sample for the Human Connectome Project for Early Psychosis (HCP-EP) included 223 individuals with early psychosis and 80 control subjects for a total of 303 subjects. The early psychosis participants were from 4 specialized clinical sites: Beth Israel Deaconess Medical Center (BIDMC), McLean Hospital, Massachusetts General Hospital (MGH), and Indiana University (IU). Enrollment occurred from August 2016 to April 2022.
Clinical and cognitive assessments were conducted by trained raters under the supervision of licensed psychiatrists or clinical psychologists. This transdiagnostic study utilized the Structured Clinical Interview for DSM-5 Research Version (SCID-5-RV)31 and medical records to establish Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 diagnoses.1 Based on these diagnoses, 136 participants with non-affective psychosis (eg, schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, delusional disorder, or unspecified psychosis) and 67 participants with affective psychosis (eg, major depressive disorder with psychosis or bipolar disorder with psychosis) were identified. Both subgroups were restricted to individuals with an illness duration of less than 5 years (mean duration = 1.9 years, standard deviation = 1.4 years). Eighty healthy controls were recruited from the same sites via locally approved advertisements, online platforms, and referrals, and matched for age, sex, and parental socioeconomic status to the HCP-EP sample at each site. The inclusion and exclusion criteria for study participants are detailed in Supplementary Method S1.
The study received ethical approval from the coordination center at Brigham and Women’s Hospital (BWH) via the Partners Institutional Review Board for the Boston area sites (BIDMC, McLean, and MGH). In addition, ethical approval was obtained from the Indiana University Institutional Review Board.
Demographic, Clinical, and Cognitive Assessments
Demographic data, including parental socioeconomic status,32 chlorpromazine-equivalent doses,33-36 and full-scale intelligence quotient (IQ),37 were collected. Clinical symptoms, encompassing positive, negative, and general domains, were evaluated using the Positive and Negative Syndrome Scale (PANSS).38,39 Cognitive function was assessed through 7 NIH Toolbox tests,40-42 with composite scores for fluid and crystallized cognition derived from age- and sex-adjusted T-scores.43 Detailed information on the demographic, clinical, and cognitive assessments is provided in Supplementary Method S2.
Image Acquisition and Preprocessing
Imaging data for all Boston area sites were initially collected at BWH, with McLean added as an additional MRI site in April 2018. Indiana University has consistently conducted scans at its facility. All imaging data were acquired using Siemens MAGNETOM Prisma 3 T scanners (Siemens, Erlangen, Germany). At BWH and IU, scanners were equipped with 32-channel head coils, while the McLean scanner featured a 64-channel head and neck coil. The details of the imaging protocols are provided in Supplementary Method S3.
Our in-house pipeline, available on GitHub (https://github.com/pnlbwh/luigi-pnlpipe), integrates distinct processing modules for imaging data analysis.
For structural data, raw DICOM files for T1-weighted (T1w) and T2-weighted (T2w) scans were obtained from 289 participants (210 early psychosis participants and 79 controls), converted to NIFTI format, and then aligned to standard axes and centered. Brain masks for T2w images were generated using the high-definition brain extraction tool (HD-BET),44 followed by visual quality inspection and manual editing when necessary. These masks were registered to T1w images using rigid registration of Advanced Normalization Tools (ANTs). The masked T1w and T2w images were then corrected for bias fields.
Diffusion weighted images were collected from 286 participants, converted from DICOM to NIFTI format, aligned, centered, and subjected to semi-automated quality control. The processed diffusion data underwent Gibbs unringing to remove ringing artifacts,45 brain masking, the process of extracting the brain from the skull, was performed using a convolutional neural network-based approach.46 In addition, corrections for motion artifacts and eddy currents were conducted using the Functional Magnetic Resonance Imaging of the Brain Software Library.47 Echo planar imaging distortion was also corrected to mitigate intensity loss and voxel displacement caused by magnetic field inhomogeneity and interactions.48
Harmonization of the diffusion signals at b = 1500 s/mm2 across the 3 scanners was conducted to reduce scanner-related bias, using our retrospective method.49,50 For this retrospective method, BWH was designated as the reference site, with McLean and IU as target sites. We first identified the scanner-related differences between the reference and target sites by generating rotation-invariant spherical harmonics feature templates from a subset of age- and sex-matched healthy controls (10-20 subjects per site). Subsequently, we applied the learned scanner-related differences to those templates to harmonize the diffusion data in all participants across the sites. Seven participants, including 3 individuals with early psychosis and 4 healthy controls, were excluded due to harmonization errors.
FreeSurfer Processing, LGI Calculation, and Designing Analysis Area
The masked T1w images were processed using FreeSurfer software (v7.1.0), employing a standardized automatic reconstruction pipeline.51 Subsequently, the preprocessed images were parcellated into 176 gray and white matter regions based on the Desikan–Killiany Atlas.52 To delineate the 4 cortical lobes (frontal, temporal, parietal, and occipital), corresponding gray matter regions defined by the Desikan–Killiany Atlas were merged.
As part of the standard FreeSurfer processing, three-dimensional cortical surface models comprising approximately 150 000 vertices were reconstructed. Using these surface models can resolve the issue of buried sulci, which causes inaccurate gyrification index measurements. The next step involved employing a matching algorithm to generate a smooth outer surface, which virtually envelops the exterior of the brain, aligning vertices on the outer surface with those on the cortical (inner) surface. Within this framework, spherical brain regions with a 25-mm radius were defined, and LGI maps were computed by calculating the ratio of the inner to outer surface area for each vertex. Inter-subject registration was then performed to enable vertex-level statistical group comparisons.26
Once LGI was calculated, vertex-wise group differences were tested (see “Statistical Analysis”). The brain ROI exhibiting LGI group differences (ie, left perisylvian cortex) was used for the subsequent correlational analyses with the advanced diffusivity indices (Figure 1). The analysis of group comparison in LGI was performed in the fsaverage (Montreal Neurological Institute 305; MNI305) space, which is commonly used to align individual cortical surfaces to a common template for group-level vertex-wise comparisons. The resulting brain ROI exhibiting LGI group differences (ie, left perisylvian cortex) was then mapped to T1w space for each subject via the FreeSurfer function mri_label2label. This surface-based representation of brain ROI exhibiting LGI group differences (ie, left perisylvian cortex) was then converted to a 3D volumetric representation using the FreeSurfer tools (mri_label2vol, mri_binarize, and mris_calc). An average LGI value was extracted by averaging the LGI values across all vertices within the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex). These LGI values from all participants (individuals with early psychosis and healthy controls) were harmonized jointly across the 3 scanning sites using the ComBat method,53 with site treated as the batch variable and age and sex included as covariates. Prior to harmonization, we confirmed that there were no significant site-specific differences in demographic characteristics (ie, age, sex, and education). This approach employs Bayesian estimation to account for site-specific differences and to reduce measurement bias introduced by differences among multi-site scanners.
Figure 1.

Schematic diagram showing how this multimodal neuroimaging study was conducted. Firstly, a full-brain tractography with free-water model was prepared. Next, the brain region that consists of all vertices showing significant LGI differences between early psychosis and controls was set as a brain ROI exhibiting LGI group differences (ie, left perisylvian cortex). Its surface-based representation in MNI305 space were transformed into 3D volumetric representation in DWI space for each subject. For the HFA part, average HFA within the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex) was calculated. For the tractography part, tracts that originate or terminate at the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex) and connect to 4 cortical lobes were extracted from a full-brain tractography using white matter query language. This extraction enables the calculation of the tract measures. Abbreviations: DWI, diffusion-weighted imaging; ROI, region of interest; HFA, heterogeneity of fractional anisotropy; LGI, local gyrification index; MNI, Montreal Neurological Institute; T1w, T1-weighted; UKF, unscented Kalman filter.
Finally, the volumetric brain ROI exhibiting LGI group differences (ie, left perisylvian cortex) was registered from T1w to diffusion weighted imaging space through rigid ANTs registration. This allowed for the calculation of the average HFA value for each individual within the same brain region and the extraction of white matter fiber tracts that either originated from or terminated in the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex).
Estimation of Cortical Cytoarchitectural Heterogeneity
To estimate gray matter cytoarchitecture, we used a diffusion-derived measure known as HFA.27 This measure was developed to address limitations of traditional gray matter cytoarchitecture measures, which are susceptible to voxel-by-voxel signal fluctuations in gray matter54 and partial volume effects from extracellular components.55 Heterogeneity of fractional anisotropy has been shown to be sensitive to variations in the cytoarchitectural characteristics of gray matter tissue within selected regions, possibly reflecting cellular composition and their spatial distribution within the cortical layers.56
Fractional anisotropy maps corrected for free-water were calculated for each voxel by fitting the free-water model using the code in MATLAB R2017a (Mathworks, Natick, MA, USA).28 Free-water correction was applied in the FA calculation to avoid partial volume effects from the extracellular component,55 especially around the border between gray matter and cerebrospinal fluid. The FA maps generated for all subjects underwent rigorous visual quality control, leading to the exclusion of 8 subjects-3 individuals with early psychosis and 5 healthy controls-due to low-quality FA maps. The average HFA27 within the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex) was then calculated (Figure 1) in MATLAB R2017a using the following formula:
![]() |
where N is the total number of voxels within the region of interests, and m is the FA value in a voxel, indexed by i or j.
Estimation of White Matter Microstructural Measures
To investigate white matter microstructural properties associated with altered cortical folding in psychosis, FA values were analyzed along white matter tracts connecting regions exhibiting LGI changes.
Given the balance between sensitivity to fiber structure and signal-to-noise ratio,57 diffusion data with a b-value of 1500 s/mm2 were employed for whole-brain tractography. The harmonized diffusion data were processed using the Unscented Kalman Filter (UKF) tractography algorithm, which enhances fiber tracking accuracy by incorporating information from prior steps during the tracking process.58,59 A combined model was used, incorporating the 2-tensor model for detecting crossing fibers60,61 and the free-water model to preserve accurate fiber orientation by reducing contamination from extracellular free-water.62 The UKF tractography reconstructed whole-brain white matter fiber bundles. Consistent UKF parameters were applied as follows: Voxels within the brain mask with FA values above 0.1 were seeded to exclude regions with low diffusion directionality, ensuring more reliable fiber tracking. Tracking was terminated when FA dropped below 0.08 or the normalized mean signal fell below 0.06. The normalized mean signal, calculated as the sum of normalized signals across all gradient directions for each voxel, reflects the overall quality and integrity of the diffusion data. To avoid bias from excessively short fibers, only fibers longer than 40 mm were retained.63-65
White Matter Query Language (WMQL),66 an automated tool for segmenting fiber tracts based on anatomically defined gray matter regions in any anatomical atlas, was employed to identify tracts originating or terminating in the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex). In this study, after co-registering T1w images with diffusion data,67 we used the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex) along with frontal, temporal, parietal, and occipital lobes defined by FreeSurfer as origin and termination points of the streamlines, applying additional exclusion criteria to eliminate stray fibers (Figure 1). Finally, free-water corrected diffusivity metrics were extracted for each tract, including FA (a representative measure of white matter integrity), mean diffusivity (MD; an overall measure of diffusion), axial diffusivity (AD; reflecting axonal integrity), and radial diffusivity (RD; assessing myelin integrity).30 Combining these metrics facilitates a comprehensive assessment of white matter microstructure, including axonal degeneration and myelin injury.68
Statistical Analysis
Demographic differences between the early psychosis and control groups were examined using a one-way analysis of variance (ANOVA) for continuous variables or the chi-square test for categorical variables (P < .05, 2-tailed) using SPSS version 27.0.1.0 (IBM Corp., Armonk, NY).
Local gyrification index was compared between groups of 203 individuals with early psychosis and 73 healthy controls who had both preprocessed T1w and diffusion weighted images and for whom LGI could be successfully calculated. Three participants, including 1 individual with early psychosis and 2 healthy controls, were excluded due to LGI calculation errors. Each vertex-wise LGI value was mapped onto the fsaverage space and smoothed at a 5-mm Gaussian kernel. To estimate group differences (early psychosis vs control; non-affective vs control; affective vs control; and non-affective vs affective) in LGI values, a general linear model adjusted for age, sex, and scanning site was performed using the mri_glmfit command. The FreeSurfer program enables vertex-wise analysis of cortical metrics, including LGI, providing statistical maps to identify spatially localized group differences. A cluster-wise correction for multiple comparisons was applied using precomputed Monte Carlo simulations derived from 10 000 iterations, with a vertex-wise threshold of P < .05 (2-tailed), to identify vertices with significant group differences.
SPSS version 27.0.1.0 was also employed to conduct the following correlation analyses. Correlations between the average LGI values within the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex) and the advanced diffusivity indices were performed separately for the early psychosis and control groups. The relationship between the average LGI and HFA values at the corresponding brain region was examined using Spearman’s rank correlation coefficients after regressing out the effects of age and sex, setting a statistical threshold at P < .05 (2-tailed), as both values were not normally distributed by the Kolmogorov–Smirnov test. Furthermore, to determine whether the association between LGI and HFA was region-specific, average LGI and HFA values in the whole brain cortex as a control region were also calculated and subjected to Spearman’s rank correlation analyses.
Similarly, the association between the average LGI values and the average FA values of the 4 connections (ie, frontal, temporal, parietal, and occipital tract) were examined using Spearman’s rank correlation coefficients, after adjusting for age and sex. The statistical threshold was set to P < .013, reflecting Bonferroni correction for the 4 tracts. As a post hoc analysis of the significant association between LGI and FA, we examined the relationship between average LGI values and other diffusivity indices (ie, average AD, MD, and RD) within the connection, applying a statistical threshold of P < .013 (Bonferroni correction for the 4 indices).
If a significant relationship between the average LGI values and these advanced diffusivity indices was found in the early psychosis group, we performed supplementary analyses. Their associations were further examined within the early psychosis subgroups using the same statistical thresholds.
Given the significant association of LGI with HFA and frontal FA, we further explored the relationship between average LGI values and average HFA values, both within the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex), as well as the average FA values in the frontal connection with clinical symptoms and cognitive performance. Variables included PANSS positive symptom score (n = 152), PANSS negative symptom score (n = 150), PANSS general symptom score (n = 151), PANSS disorganization symptom score (n = 150), NIH Toolbox Fluid Cognition Composite score (n = 142), and NIH Toolbox Crystallized Cognition Composite score (n = 143). Multiple linear regression analyses were performed with each clinical or cognitive variable as the dependent variable and average LGI, HFA, and FA values in the frontal connection as independent variables. Age and sex were included as covariates for PANSS scales, along with the antipsychotic medication dose. The statistical threshold was set at P < .0083 after Bonferroni correction for the 6 variables (ie, PANSS positive, negative, general, and disorganization symptom scores, as well as Fluid and Crystallized Cognition Composite scores). PANSS disorganization symptom scores were calculated by summing specific PANSS subscales (P4, N5, G10, and G11) based on previous literature.69 A post-hoc analysis was performed if significant associations were identified between LGI, HFA, and FA in the frontal connection and clinical or cognitive variables. If statistically significant associations were identified, further analyses were conducted on the relevant subscales, with Bonferroni-corrected thresholds adjusted for the number of items. Such post-hoc analyses were also performed in both non-affective and affective subgroups.
In addition, the association of the imaging measures (ie, LGI, HFA, and frontal FA) with medication (antipsychotic medication dose [n = 179]) was assessed using Spearman’s rank correlation coefficients, after controlling for age and sex, with the statistical threshold set at P < .017 after Bonferroni correction for the 3 imaging measures.
Moreover, the relationship between the average LGI values within the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex) and the number of past psychiatric hospitalizations, which partially reflect relapse history,70 was assessed using Spearman’s rank correlation coefficients, after controlling for age and sex, with the statistical threshold set at P < .05.
Results
Demographic Background
The demographic characteristics of the study participants are summarized in Table 1 and Supplementary Table S1. While the healthy control group had a higher education level than the early psychosis group, the parental socioeconomic level was comparable between the 2, which is expected based on social drift observed in those with psychosis compared to their family origin.71 There was also a group difference in handedness. The early psychosis group also had a significantly lower full-scale IQ and lower fluid cognition ability compared with the healthy control group.
Table 1.
Characteristics of Study Participants
| Healthy controls | Early psychosis | Test statistic | P value | |
|---|---|---|---|---|
| Number of subjects (total), no. of subjects [n = 276] | 73 | 203 | ||
| Scanning site 1 (Indiana University), no. of subjects [n = 126] | 23 | 103 | ||
| Scanning site 2 (Brigham and Women’s Hospital), no. of subjects [n = 76] | 33 | 43 | ||
| Scanning site 3 (McLean Hospital), no. of subjects [n = 74] | 17 | 57 | ||
| Sex, male/female, no. [n = 276] | 41/32 | 123/80 | χ2(1) = 0.436 | .509 |
| Age, years, mean (SD) [n = 276] | 23.9 (3.6) | 23.1 (3.8) | F(1,275) = 2.491 | .116 |
| Education level, mean (SD)a [n = 276] | 8.7 (2.1) | 6.5 (2.2) | F(1,275) = 55.388 | <.001 |
| Parental socioeconomic level, mean (SD)b [n = 264] | 2.1 (1.0) | 2.3 (1.2) | F(1,263) = 2.070 | .151 |
| Handedness, right/left/ambidextrous, no.c [n = 275] | 60/13/0 | 177/17/8 | χ2(2) = 7.411 | .025 |
| Duration of illness, years, mean (SD)d [n = 200] | 1.9 (1.4) | |||
| Antipsychotic medication dose, chlorpromazine equivalent mg/day, mean (SD)e [n = 180] | 308.3 (314.3) | |||
| The number of past psychiatric hospitalization, mean (SD)f [n = 200] | 2.1 (1.8) | |||
| WASI-II Full Scale IQ score estimate, mean (SD)g [n = 269] | 116.0 (11.3) | 105.5 (15.6) | F(1,268) = 27.011 | <.001 |
| PANSS | ||||
| PANSS positive symptom score, mean (SD)h [n = 197] | 14.2 (5.2) | |||
| PANSS negative symptom score, mean (SD)i [n = 194] | 12.0 (5.3) | |||
| PANSS general symptom score, mean (SD)j [n = 196] | 10.8 (3.0) | |||
| NIH Toolbox | ||||
| Fluid Cognition Composite score, mean (SD)k [n = 246] | 50.8 (10.0) [n = 65] | 38.7 (11.4) [n = 181] | F(1,245) = 57.361 | <.001 |
| Crystallized Cognition Composite score, mean (SD)l [n = 248] | 57.8 (10.6) [n = 65] | 56.0 (11.7) [n = 183] | F(1,247) = 1.304 | .255 |
| Intracranial Volume, cm3, mean (SD)m [n = 276] | 1040.9 (114.6) | 1021.4 (121.6) | F(1,275) = 1.430 | .233 |
Abbreviations: PANSS, Positive and Negative Syndrome Scale; WASI-II, Wechsler Abbreviated Scale of Intelligence-II.
Education level is the highest education level completed by the participant: 1 = elementary school, 2 = middle/junior high school, 3 = high school, no degree, 4 = GED, 5 = high school, degree, 6 = vocational school, 7 = some university courses, 8 = associate’s degree, 9 = bachelor’s degree, 10 = some graduate level courses, 11 = master’s degree, 12 = doctorate level courses, 13 = doctorate degree.
Data missing for 12 individuals. Using the Hollingshead Four-Factor Parental Socioeconomic Status Scale, parent socioeconomic level was assessed. Education and occupation scores of parents and guardians were weighted to produce a single score (1 being the greatest SES classification, 5 being the lowest SES classification).
Data missing for an individual.
Data missing for 3 individuals.
Different antipsychotic dosages were converted into chlorpromazine equivalents. Data available for 180 individuals.
Data missing for 3 individuals.
Data missing for 7 individuals.
Data missing for 6 individuals.
Data missing for 9 individuals.
Data missing for 7 individuals.
Data missing for 30 individuals.
Data missing for 28 individuals.
For group comparisons, an analysis of covariance with age as a covariate was performed.
Group Comparison of LGI
Compared to the healthy control group, the early psychosis group had a significantly lower LGI in the superior temporal gyrus, middle temporal gyrus, banks of the superior temporal sulcus, and supramarginal gyrus in the left hemisphere (Figure 2; Supplementary Table S2). No brain regions were identified where the early psychosis group had a significantly higher LGI compared to the healthy control group. The vertices with significant LGI group difference are aggregated into the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex), which is subsequently used in the following correlational analyses. The average LGI of the vertices within this ROI was significantly reduced in the early psychosis group relative to healthy controls (Figure 2; diagnosis effect: F(1, 275) = 5.110, P = .025, partial η2 = 0.018). This LGI reduction persisted when handedness or current comorbid substance use disorder was included as a covariate (Supplementary Figures S1 and S2). The non-affective psychosis subgroup, compared with healthy controls, exhibited a significantly lower LGI in a similar left temporo-parietal region (Supplementary Figure S3). No statistically significant LGI differences were observed between the affective psychosis subgroups and healthy controls, as well as the non-affective and affective psychosis subgroups.
Figure 2.

Group comparison of lgi between the early psychosis and healthy control groups. (A) Cortical statistical maps displaying a reduced local gyrification index in the early psychosis group compared with the healthy control group. The maps are shown for the right and left hemispheres in lateral and medial views, respectively. The horizontal bar shows P values corrected for multiple comparisons. (B) Average LGI values of vertices within the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex) for each group. Abbreviations: EP, early psychosis; HC, healthy controls; LGI, local gyrification index; ROI, region of interest.
Relationship between LGI and HFA
Average LGI values in the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex) were positively correlated with average HFA values in the same brain region only in the early psychosis group, with statistical significance (r = 0.143, P = .044) (Figure 3; Supplementary Table S3). In the early psychosis subgroups, this positive correlation was observed only for the non-affective psychosis group (r = 0.274, P = .001) (Supplementary Table S3). However, average LGI values and average HFA in the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex) did not show a significant correlation in the healthy control group (r = −0.103, P = .405) (Supplementary Table S3). In addition, there was no significant correlation between average LGI values and average HFA in the whole brain cortex used as a control region (early psychosis group: r = 0.089, P = .209; healthy control group: r = −0.009, P = .940). These findings suggest that the significant correlation between LGI and HFA is specific to early psychosis and to the regions exhibiting gyrification alterations.
Figure 3.

Relationships between lgi and advanced diffusivity indices in the early psychosis group. (A) Scatter plots for the relationship between LGI and HFA at the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex) in the early psychosis group. (B) Scatter plots for the relationship between LGI in the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex) and average FA of the frontal tracts in the early psychosis group. (C) Scatter plots for the relationship between LGI in the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex) and average RD of the frontal tracts in the early psychosis group. Abbreviations: FA, fractional anisotropy; ROI, region of interest; HFA, heterogeneity of fractional anisotropy; LGI, local gyrification index; RD, radial diffusivity.
Relationship between LGI and Tract Measures
Lower LGI values in the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex) were significantly associated with reduced FA values in the frontal tract, but only in the early psychosis group (r = 0.212, P = .005) (Figure 3; Supplementary Table S4). In a post-hoc analysis, lower LGI values in the same brain region were significantly associated with increased RD values in the frontal tract (r = −0.224, P = .003) (Figure 3; Supplementary Table S5).
In the early psychosis subgroups, a significant relationship between lower LGI values and reduced FA values in the frontal tract was seen only in the non-affective psychosis group (r = 0.261, P = .004) (Supplementary Table S4).
Relationships of LGI, HFA, and FA in the Frontal Tract with Clinical and Cognitive Variables
Multiple regression analyses showed a significant association between the average LGI values in the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex) and PANSS negative symptom score (adjusted R2 = 0.081, standardized β = −0.2340, T = −2.7820, P = .0061; semi-partial r = −0.219, sr2 = 0.048) (Table 2). The association between average HFA values in the same brain regions and NIH Toolbox Fluid Cognition Composite score was detected (adjusted R2 = 0.049, standardized β = −0.1810, T = −2.1570, P = .0330; semi-partial r = −0.177, sr2 = 0.031), but it did not reach the Bonferroni-corrected significance level (Table 2).
Table 2.
Multiple Regression Analyses in the Early Psychosis Group: LGI, HFA, and FA in the Frontal Tract = > Clinical or Cognitive Variables
| Clinical or cognitive variables | PANSS positive symptom score | PANSS negative symptom score | PANSS general symptom score | PANSS disorganization symptom score | NIH Toolbox Fluid Cognition Composite score | NIH Toolbox Crystallized Cognition Composite score | |
|---|---|---|---|---|---|---|---|
| Adjusted R2 | 0.00700 | 0.08100 | 0.00700 | 0.00017 | 0.04900 | 0.01400 | |
| LGI | Standardized β | −0.0340 | −0.2340 | −0.0420 | −0.0250 | 0.0260 | 0.1370 |
| T | −0.3900 | −2.7820 | −0.4840 | −0.2870 | 0.3010 | 1.5660 | |
| p | 0.6970 | 0.0061** | 0.6290 | 0.7750 | 0.7640 | 0.1200 | |
| HFA | Standardized β | 0.0680 | −0.0460 | 0.0350 | 0.0330 | −0.1810 | −0.0060 |
| T | 0.8100 | −0.5620 | 0.4120 | 0.3830 | −2.1570 | −0.0750 | |
| p | 0.4190 | 0.5750 | 0.6810 | 0.7020 | 0.0330* | 0.9400 | |
| FA in the frontal tract | Standardized β | 0.0150 | 0.0840 | 0.0590 | 0.0290 | 0.1480 | −0.0290 |
| T | 0.1740 | 1.0400 | 0.7000 | 0.3490 | 1.7380 | −0.3300 | |
| P | .8620 | .3000 | .4850 | .7280 | .0850 | .7420 |
Abbreviations: FA, fractional anisotropy; HFA, heterogeneity of fractional anisotropy; LGI, local gyrification index; PANSS, Positive and Negative Syndrome Scale.
* P < .05, uncorrected statistical significance level.
** P < .0083, statistical significance level after Bonferroni correction for the 6 variables.
In the post-hoc analyses of early psychosis participants, the PANSS negative symptom subscale scores showed significant associations between average LGI values in the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex) and blunted affect (adjusted R2 = 0.0750, standardized β = −0.2310, T = −2.7670, P = .0060; semi-partial r = −0.216, sr2 = 0.047) as well as lack of spontaneity and flow of conversation (adjusted R2 = 0.0960, standardized β = −0.2480, T = −3.0040, P = .0030; semi-partial r = −0.232, sr2 = 0.054) (Supplementary Table S6). Similar results were observed in both non-affective and affective subgroups (Supplementary Tables S7 and S8).
There were no significant relationships between average LGI values or average HFA values, either in the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex), nor in average FA values in the frontal tract, or antipsychotic medication dose (Supplementary Table S9).
Lower LGI values in the brain ROI exhibiting LGI group differences (ie, left perisylvian cortex) were significantly associated with a higher number of past psychiatric hospitalizations (r = −0.132, P = .030).
Discussion
Our results demonstrate alterations in the cortical folding patterns assessed by LGI. These alterations were localized to the left temporo-parietal region in early psychosis participants. Moreover, the temporo-parietal LGI changes were significantly associated with temporo-parietal altered HFA (ie, non-uniform tissue organization within the cortical layer). Furthermore, lower temporo-parietal LGI was associated with reduced FA and increased RD (ie, disturbed myelin integrity) in the white matter tracts that connect this region to the frontal lobe. Finally, decreased temporo-parietal LGI was related to more severe negative symptoms. These findings provide in vivo evidence of the interrelationships between alterations in cortical folding, cortical cytoarchitecture, and ipsilateral long-range white matter microstructure, which may be involved in the symptomatology of psychosis.
Specifically, the current study demonstrates lower LGI in the left temporo-parietal region in the early psychosis group compared with healthy controls. The lower LGI may correspond to both sulcal widening and diminished sulcal depth.7 Previous findings in schizophrenia reported both higher and lower LGI. In the first-episode schizophrenia group, the majority of studies report higher LGI.12,13 Notably, our HCP-EP dataset had longer mean duration of illness (1.9 years) and a higher illness duration as defined by inclusion criteria (within 5 years of illness onset) than those in the previous study cited (mean = 0.9 years; maximum was within 1 year of illness onset except for first psychiatric hospitalization).13 Nonetheless, a lower LGI in schizophrenia has been reported in subjects with a similar period of illness duration to those of the HCP-EP dataset.72,73 Interestingly, our study also revealed an association between the reduced LGI and increased number of past psychiatric hospitalization. Taking these observations into account, a progressive LGI reduction after illness onset73,74 may partially explain the variability in gyrification findings in psychotic disorders, potentially reflecting cortical plasticity changes around the onset of psychosis. The LGI shifts from hypergyria to hypogyria along the schizophrenia time course may reflect remodeling or compensatory processes,75 and may be analogous to cortical thickness changes previously reported.76 Such LGI trajectories may be observed across broad neurodevelopmental disorders,16 including very preterm babies with cognitive deficits in their adulthood.77 Another consideration is the transdiagnostic sample composition in the present dataset, given the patterns of gyrification deviations, as well as those of cortical and white matter deterioration, in schizophrenia and bipolar disorder might differ.78,79 On the other hand, it is also noteworthy that other psychiatric conditions (eg, obsessive-compulsive disorder) do not report low LGI pattern in the same left temporo-parietal region.80
The brain region exhibiting lower LGI encompassed the primary auditory cortex and temporo-parietal junction (TPJ). Similarly, an earlier study on schizophrenia reported sulco-gyral pattern anomalies in the temporal lobe,11 supramarginal gyrus,81 and parietal operculum82 of the left hemisphere. The affected brain region was localized exclusively in the left hemisphere, possibly reflecting inherent vulnerability of language-related networks, predominantly centered on the left perisylvian cortex, to psychosis.83 Functional brain changes in these brain regions have also been implicated in auditory hallucinations84 and delusions of reference85 in chronic schizophrenia cases. However, the present study found no significant association between altered cortical folding and positive symptoms. Given that psychotic symptoms fluctuate throughout the illness course86 and specific auditory verbal hallucination scores were unavailable,87 the absence of an association between LGI and positive symptoms must be interpreted with caution. Likewise, genuine biological heterogeneity within the psychosis spectrum88 may have contributed to the lack of correlation, indicating that future validation through subtyping studies is warranted.
An abnormal cortical folding pattern in psychotic disorders, as reported here, may be underpinned by gray matter cytoarchitectural changes. The postmortem findings in individuals with schizophrenia report smaller pyramidal cells and fewer dendritic spines in layer III of frontal and temporal cortices.89-91 In addition, transcriptomic differences in layer III pyramidal cells of the prefrontal cortex relative to healthy controls were minimal in bipolar disorder, yet pronounced in schizophrenia.92 Since our study demonstrates a significant association between LGI and HFA in the temporo-parietal region, this may indeed suggest that gyrification changes in psychosis, notably in non-affective cases, arise from pathological changes involved in the formation of cortical layers.
In addition to local cortical abnormalities, our study also demonstrates that the abnormal cortical folding observed especially in non-affective psychosis, might be related to white matter connections between the TPJ and the frontal lobe. These connections are composed primarily of the arcuate fasciculus93 and superior longitudinal fasciculus II, which are involved in language processing and verbal working memory.94,95 Given that the cortical layer III includes many long-range projection neurons,96 the aforementioned alterations in pyramidal cell morphology89,91 may implicate an involvement of fronto-temporal circuitry.97,98 Specifically, the present finding of a significant association between lower LGI and reduced white matter microstructure could imply that fewer, or less myelinated/less coherent axons might lead to reduced cortical folding. Such a finding is also consistent with a tension-based theory,18 proposing that during brain development, the group of axons, by pulling together, generates mechanical force to induce folding of the cortical sheet.
Finally, more severe negative symptoms may be partly explained by the degree of diminished complexity of brain folding. Conversely, LGI reductions were partly accounted for by negative symptoms (Supplementary Table S10). Our findings are consistent with a prior study that also reports temporal LGI associations occur with negative symptoms in antipsychotic-naïve first-episode schizophrenia individuals.99 Among negative symptoms, blunted affect has been particularly associated with frontal dysconnectivity.100 Assuming that changes in gyrification and white matter microstructure reside on the same etiological pathway since they were interrelated, the fronto-temporal dysconnectivity may provide anatomical support for the disconnection hypothesis of psychosis,101 possibly being responsible for the type II syndrome,102 which is mainly composed of negative symptoms.103,104 Accumulating neuroimaging evidence linking connectivity metrics to clinical manifestations, as exemplified by the present study, may facilitate the development of novel neuromodulation targets.105 Indeed, recent transcranial direct current stimulation protocols targeting the TPJ-frontal circuit have been shown to alleviate overall psychopathology, including negative symptoms, in individuals with schizophrenia.106
Limitations
A few limitations should, nonetheless, be noted. First, the majority of early psychosis individuals were taking antipsychotics at the time of scanning. The possibility that antipsychotic medications may have confounded the brain structural findings in psychotic disorders cannot be ruled out, particularly given some prior findings.107 However, we did not find any significant associations between these measures and antipsychotic medication dosage, which is consistent with previous studies showing no effect of antipsychotic medication on LGI,108 HFA,109 or FA.110 Second, while we report subtle imaging metric alterations in early psychosis using large sample size in a multi-site design, the effect sizes for associations among imaging metrics were small to moderate, which aligns with previous studies.78,111-113 While these statistically significant correlations reflect subtle developmental signatures, future investigations should examine additional brain features underlying anomalous gyrification. Third, the present vertex-wise analysis focused on identifying localized LGI abnormalities. However, given that schizophrenia is underpinned by whole-brain connectivity disturbances,114 this investigation should be complemented by methods optimized to detect network-level LGI anomalies.115,116 Accordingly, network-wise analyses examining the relationship between LGI and white matter indices in psychosis may be also useful.117 Fourth, although HFA is a suggested surrogate marker of cytoarchitecture and has been validated in an animal study,56 diffusion imaging has been primarily applied to white matter microstructure, and in gray matter it is confounded by partial volume effects much more than in white matter. We minimized these effects by using high-resolution data and free-water correction, but the model limitations (eg, unmodeled exchange between compartments) still exist.109 Moreover, while HFA does capture cellular composition and spatial distribution, it does not encompass other biological factors that partly contribute to cytoarchitecture (eg, synapse, dendrite, myelin, and axon).56 Therefore, future multimodal studies should validate our findings using more sophisticated models for cytoarchitecture of gray matter. Lastly, this study employed a cross-sectional design, making it difficult to determine whether the observed brain structural alterations reflect static deficits from early neurodevelopment, progressive brain pathology in later stages, or a combination of both.118 Notably, variations in the direction of LGI abnormalities, inconsistencies in their locations across studies, and our own findings on the association between LGI and white matter tracts suggest that LGI may be dynamically influenced by white matter maturation. Nevertheless, it is imperative to establish whether white matter maturation drives the LGI decline. Future multimodal neuroimaging studies with a longitudinal framework are warranted to examine the causal relationships between progressive changes in cortical folding and diffusivity measures along the disease course, while restricting subjects to more stratified cohorts (ie, affective or non-affective subgroups, DSM-based diagnostic categories).
Conclusions
By integrating advanced MRI techniques into our multimodal neuroimaging study, we provide the first in vivo evidence suggestive of specific mechanisms underlying anomalous cortical folding in psychosis. Particularly in non-affective psychosis, diminished complexity of cortical folding is underlain by cortical layer microstructural disorganization and long-range white matter tracts with less myelination and coherence. These relationships partially support the tension-based cortical morphogenesis.18 Further longitudinal multimodal neuroimaging studies are required to better understand the nature and dynamics of fronto-temporal circuitry abnormalities across psychosis subgroups, as well as their functional consequences along their time-course.
Supplementary Material
Acknowledgments
The authors extend their gratitude to all participants for their invaluable contributions to this study, as well as to the research staff responsible for data collection and management.
Contributor Information
Daiki Sasabayashi, Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02145, United States; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama 930-0194, Japan; Research Center for Idling Brain Science, University of Toyama, Toyama 930-0194, Japan.
Johanna Seitz-Holland, Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02145, United States; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, United States.
Yogesh Rathi, Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02145, United States; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, United States; Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, United States.
Nicholas Kim, Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02145, United States.
Kang Ik K Cho, Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02145, United States.
Dheshan Mohandass, Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02145, United States.
Tashrif Billah, Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02145, United States.
Anastasia Haidar, Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02145, United States.
Elana Kotler, Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02145, United States.
Suheyla Cetin-Karayumak, Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02145, United States; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, United States.
Grace R Jacobs, Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02145, United States.
Cornelius Berberich, Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02145, United States.
Kathryn E Lewandowski, Department of Psychiatry, McLean Hospital, Harvard Medical School, Belmont, MA 02478, United States.
Raquelle I Mesholam-Gately, Department of Psychiatry, Massachusetts Mental Health Center Public Psychiatry Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, United States.
Joanne Wojcik, Department of Psychiatry, Massachusetts Mental Health Center Public Psychiatry Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, United States.
Moritz Haaf, Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02145, United States; Department of Psychiatry and Psychotherapy, Psychiatry Neuroimaging Branch (PNB), University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
Shinsuke Koike, The University of Tokyo Institute for Diversity and Adaptation of Human Mind, The University of Tokyo, Tokyo 153-8902, Japan; Center for Evolutionary Cognitive Sciences, Graduate School of Art and Sciences, The University of Tokyo, Tokyo 153-8902, Japan; International Research Center for Neurointelligence, The University of Tokyo Institutes for Advanced Study, The University of Tokyo, Tokyo 113-0033, Japan.
Yoji Hirano, Department of Psychiatry, Faculty of Medicine, Division of Clinical Neuroscience, University of Miyazaki, Miyazaki 889-1692, Japan; Institute of Industrial Science, The University of Tokyo, Tokyo 153-8505, Japan.
Tsutomu Takahashi, Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama 930-0194, Japan; Research Center for Idling Brain Science, University of Toyama, Toyama 930-0194, Japan.
Michio Suzuki, Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama 930-0194, Japan; Research Center for Idling Brain Science, University of Toyama, Toyama 930-0194, Japan.
Ofer Pasternak, Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02145, United States; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, United States; Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, United States.
Matcheri S Keshavan, Department of Psychiatry, Massachusetts Mental Health Center Public Psychiatry Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, United States.
Daphne Holt, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, United States.
Dost Öngür, Department of Psychiatry, McLean Hospital, Harvard Medical School, Belmont, MA 02478, United States.
Alan Breier, Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN 46202, United States.
Michael J Coleman, Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02145, United States.
Sylvain Bouix, Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02145, United States; Department of Software Engineering and Information Technology, École de Technologie Supérieure, Université du Québec, Montréal, QC H3C 1K3, Canada.
Martha E Shenton, Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02145, United States; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, United States; Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, United States.
Marek Kubicki, Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02145, United States; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, United States; Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, United States.
Funding
The present study was supported by JSPS KAKENHI Grant Numbers JP18K15509 and JP22K15745 to D.S., JP24K10704 to T.T., JP19H03579 and JP24K02378 to S.K., JP20KK0193, JP21H02851, and JP23K21414 to Y.H., and JP20H03598 to M.S., AMED Grant Number JP24wm0625302 to T.T., Y.H., and S.K., and the Health and Labour Sciences Research Grants for Comprehensive Research on Persons with Disabilities Grant Numbers JP16dk0307029 and JP20dk0307094 to M.S. The current study was also supported by SENSHIN Medical Research Foundation to T.T. and by NIMH Grant Numbers U01MH109977 to M.E.S., Y.R., K.E.L., R.I.M., J.W., O.P., M.S.K., D.H., D.Ö., A.B., M.J.C., S.B., R01-MH136503 to M.K., O.P., R01MH119222 to Y.R., R01MH117012 to K.E.L., and K99MH131850 to J.S.-H. We also acknowledge funding provided by the Brain and Behavior Research Foundation (BBRF): Young Investigator Award to S.C.-K. and J.S.-H., and a Distinguished Investigator Award to M.K. This research was additionally supported by BBRF Young Investigator grant (funded by Mary and John Osterhaus and the Brain & Behavior Research Foundation) to J.S.-H. and Women’s Brain Initiative Pilot Award from Brigham and Women’s Hospital to J.S.-H.
Conflicts of Interest
The all authors declare no competing interests.
Data Availability
The datasets generated and analyzed during the current study are not publicly available due to reasons of data privacy and regulatory/ethical approvals, but aggregate-level data are available from the corresponding author upon reasonable request and pending local and national data protection and ethics regulations.
References
- 1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders 5th edn. American Psychiatric Publishing, Washington, D.C., 2013. [Google Scholar]
- 2. Jauhar S, Johnstone M, McKenna PJ. Schizophrenia. Lancet. 2022;399:473–486. 10.1016/S0140-6736(21)01730-X [DOI] [PubMed] [Google Scholar]
- 3. Onitsuka T, Hirano Y, Nakazawa T, et al. Toward recovery in schizophrenia: current concepts, findings, and future research directions. Psychiatry Clin Neurosci. 2022;76:282–291. 10.1111/pcn.13342 [DOI] [PubMed] [Google Scholar]
- 4. Maynard TM, Sikich L, Lieberman JA, LaMantia AS. Neural development, cell-cell signaling, and the “two-hit” hypothesis of schizophrenia. Schizophr Bull. 2001;27:457–476. 10.1093/oxfordjournals.schbul.a006887 [DOI] [PubMed] [Google Scholar]
- 5. Nakamura M, Nestor PG, McCarley RW, et al. Altered orbitofrontal sulcogyral pattern in schizophrenia. Brain. 2007;130:693–707. 10.1093/brain/awm007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Millan MJ, Andrieux A, Bartzokis G, et al. Altering the course of schizophrenia: progress and perspectives. Nat Rev Drug Disc. 2016;15:485–515. 10.1038/nrd.2016.28 [DOI] [PubMed] [Google Scholar]
- 7. Alemán-Gómez Y, Janssen J, Schnack H, et al. The human cerebral cortex flattens during adolescence. J Neurosci. 2013;33:15004–15010. 10.1523/JNEUROSCI.1459-13.2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Budday S, Steinmann P, Kuhl E. Physical biology of human brain development. Front Cell Neurosci. 2015;9:257. 10.3389/fncel.2015.00257 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Zilles K, Palomero-Gallagher N, Amunts K. Development of cortical folding during evolution and ontogeny. Trends Neurosci. 2013;36:275–284. 10.1016/j.tins.2013.01.006 [DOI] [PubMed] [Google Scholar]
- 10. Zilles K, Armstrong E, Schleicher A, Kretschmann HJ. The human pattern of gyrification in the cerebral cortex. Anat Embryol. 1988;179:173–179. 10.1007/BF00304699 [DOI] [PubMed] [Google Scholar]
- 11. Kikinis R, Shenton ME, Gerig G, et al. Temporal lobe sulco-gyral pattern anomalies in schizophrenia: an in vivo MR three-dimensional surface rendering study. Neurosci Lett. 1994;182:7–12. 10.1016/0304-3940(94)90192-9 [DOI] [PubMed] [Google Scholar]
- 12. Schultz CC, Koch K, Wagner G, et al. Increased parahippocampal and lingual gyrification in first-episode schizophrenia. Schizophr Res. 2010;123:137–144. 10.1016/j.schres.2010.08.033 [DOI] [PubMed] [Google Scholar]
- 13. Sasabayashi D, Takayanagi Y, Nishiyama S, et al. Increased frontal gyrification negatively correlates with executive function in patients with first-episode schizophrenia. Cereb Cortex. 2017a;27:bhw101. 10.1093/cercor/bhw101 [DOI] [PubMed] [Google Scholar]
- 14. Sasabayashi D, Takayanagi Y, Takahashi T, et al. Increased occipital gyrification and development of psychotic disorders in individuals with an at-risk mental state: a multicenter study. Biol Psychiatry. 2017b;82:737–745. 10.1016/j.biopsych.2017.05.018 [DOI] [PubMed] [Google Scholar]
- 15. Matsuda Y, Ohi K. Cortical gyrification in schizophrenia: current perspectives. Neuropsychiatr Dis Treat. 2018;14:1861–1869. 10.2147/NDT.S145273 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Sasabayashi D, Takahashi T, Takayanagi Y, Suzuki M. Anomalous brain gyrification patterns in major psychiatric disorders: a systematic review and transdiagnostic integration. Transl Psychiatry. 2021;11:176. 10.1038/s41398-021-01297-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Kitajima K, Tamura S, Sasabayashi D, et al. Decreased cortical gyrification and surface area in the left medial parietal cortex in patients with treatment-resistant and ultratreatment-resistant schizophrenia. Psychiatry Clin Neurosci. 2023;77:2–11. 10.1111/pcn.13482 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Van Essen DC. A tension-based theory of morphogenesis and compact wiring in the central nervous system. Nature. 1997;385:313–318. 10.1038/385313a0 [DOI] [PubMed] [Google Scholar]
- 19. Selemon LD, Goldman-Rakic PS. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry. 1999;45:17–25. 10.1016/S0006-3223(98)00281-9 [DOI] [PubMed] [Google Scholar]
- 20. Pearlson GD. Neurobiology of schizophrenia. Ann Neurol. 2000;48:556–566. 10.1002/1531-8249(200010)48:4<556::AID-ANA2>3.0.CO;2-2 [DOI] [PubMed] [Google Scholar]
- 21. Tkachev D, Mimmack ML, Ryan MM, et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 2003;362:798–805. 10.1016/S0140-6736(03)14289-4 [DOI] [PubMed] [Google Scholar]
- 22. Duchatel RJ, Shannon Weickert C, Tooney PA. White matter neuron biology and neuropathology in schizophrenia. NPJ Schizophr. 2019;5:10. 10.1038/s41537-019-0078-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Schaer M, Ottet MC, Scariati E, et al. Decreased frontal gyrification correlates with altered connectivity in children with autism. Front Hum Neurosci. 2013;7:750. 10.3389/fnhum.2013.00750 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Ecker C, Andrews D, Dell'Acqua F, et al. Relationship between cortical gyrification, white matter connectivity, and autism spectrum disorder. Cereb Cortex. 2016;26:3297–3309. 10.1093/cercor/bhw098 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Schultz CC, Wagner G, Schachtzabel C, et al. Increased white matter radial diffusivity is associated with prefrontal cortical folding deficits in schizophrenia. Psychiatry Res Neuroimaging. 2017;261:91–95. 10.1016/j.pscychresns.2017.01.011 [DOI] [PubMed] [Google Scholar]
- 26. Schaer M, Cuadra MB, Tamarit L, Lazeyras F, Eliez S, Thiran JP. A surface-based approach to quantify local cortical gyrification. IEEE Trans Med Imaging. 2008;27:161–170. 10.1109/TMI.2007.903576 [DOI] [PubMed] [Google Scholar]
- 27. Rathi Y, Pasternak O, Savadjiev P, et al. Gray matter alterations in early aging: a diffusion magnetic resonance imaging study. Hum Brain Mapp. 2014;35:3841–3856. 10.1002/hbm.22441 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Pasternak O, Sochen N, Gur Y, Intrator N, Assaf Y. Free water elimination and mapping from diffusion MRI. Magn Reson Med. 2009;62:717–730. 10.1002/mrm.22055 [DOI] [PubMed] [Google Scholar]
- 29. Jacobs GR, Coleman MJ, Lewandowski KE, et al. An introduction to the human connectome project for early psychosis. Schizophr Bull. 2025;51:658–671. 10.1093/schbul/sbae123 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Yarmarkovich A, Zhang F, O'Donnell L. Tractography Measurements. 3D Slicer Contribution and Software License Agreement. [Internet]. 2019. https://www.slicer.org/wiki/Documentation/Nightly/Modules/FiberTractMeasurements
- 31. First MB, Williams JBW, Karg RS, Spitzer RL. Structured Clinical Interview for DSM-5-Research Version (SCID-5 for DSM-5, Research Version; SCID-5-RV). American Psychiatric Publishing, 2015. [Google Scholar]
- 32. Hollingshead AB. Two Factor Index of Social Position. Yale University Press, 1957. [Google Scholar]
- 33. Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ. International consensus study of antipsychotic dosing. Am J Psychiatry. 2010;167:686–693. 10.1176/appi.ajp.2009.09060802 [DOI] [PubMed] [Google Scholar]
- 34. Leucht S, Samara M, Heres S, Patel MX, Woods SW, Davis JM. Dose equivalents for second-generation antipsychotics: the minimum effective dose method. Schizophr Bull. 2014;40:314–326. 10.1093/schbul/sbu001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Leucht S, Samara M, Heres S, et al. Dose equivalents for second-generation antipsychotic drugs: the classical mean dose method. Schizophr Bull. 2015;41:1397–1402. 10.1093/schbul/sbv037 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Leucht S, Samara M, Heres S, Davis JM. Dose equivalents for antipsychotic drugs: the DDD method. Schizophr Bull. 2016;42:S90–S94. 10.1093/schbul/sbv167 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Wechsler D. Wechsler Adult Intelligence Scale 3rd edn. The Psychological Corporation, 1997. [Google Scholar]
- 38. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261–276. 10.1093/schbul/13.2.261 [DOI] [PubMed] [Google Scholar]
- 39. Marder SR, Davis JM, Chouinard G. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. J Clin Psychiatry. 1997;58:538–546. 10.4088/JCP.v58n1205 [DOI] [PubMed] [Google Scholar]
- 40. Gershon RC, Wagster MV, Hendrie HC, Fox NA, Cook KF, Nowinski CJ. NIH toolbox for assessment of neurological and behavioral function. Neurology. 2013;80:S2–S6. 10.1212/WNL.0b013e3182872e5f [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Hodes RJ, Insel TR, Landis SC, On behalf of the NIH Blueprint for Neuroscience Research. The NIH toolbox: setting a standard for biomedical research. Neurology. 2013;80:S1. 10.1212/WNL.0b013e3182872e90 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Weintraub S, Dikmen SS, Heaton RK, et al. The cognition battery of the NIH toolbox for assessment of neurological and behavioral function: validation in an adult sample. J Int Neuropsychol Soc. 2014;20:567–578. 10.1017/S1355617714000320 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Akshoomoff N, Beaumont JL, Bauer PJ, et al. NIH Toolbox Cognition Battery (CB): composite scores of crystallized, fluid, and overall cognition. Monogr Soc Res Child Dev. 2013;78:119–132. 10.1111/mono.12038 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Isensee F, Schell M, Pflueger I, et al. Automated brain extraction of multisequence MRI using artificial neural networks. Hum Brain Mapp. 2019;40:4952–4964. 10.1002/hbm.24750 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Kellner E, Dhital B, Kiselev VG, Reisert M. Gibbs-ringing artifact removal based on local subvoxel-shifts. Magn Reson Med. 2016;76:1574–1581. 10.1002/mrm.26054 [DOI] [PubMed] [Google Scholar]
- 46. Guha Roy A, Conjeti S, Navab N, Wachinger C. QuickNAT: a fully convolutional network for quick and accurate segmentation of neuroanatomy. NeuroImage. 2019;186:713–727. 10.1016/j.neuroimage.2018.11.042 [DOI] [PubMed] [Google Scholar]
- 47. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage. 2004;23:S208–S219. 10.1016/j.neuroimage.2004.07.051 [DOI] [PubMed] [Google Scholar]
- 48. Andersson JL, Skare S, Ashburner J. How to correct susceptibility distortions in spin-echo echo-planar images: application to diffusion tensor imaging. NeuroImage. 2003;20:870–888. 10.1016/S1053-8119(03)00336-7 [DOI] [PubMed] [Google Scholar]
- 49. Billah T, Cetin-Karayumak S, Bouix S, Rathi Y. Multi-Site Diffusion MRI Harmonization. [Internet]. 2019. https://github.com/pnlbwh/dMRIharmonization
- 50. Cetin-Karayumak S, Bouix S, Ning L, et al. Retrospective harmonization of multi-site diffusion MRI data acquired with different acquisition parameters. NeuroImage. 2019;184:180–200. 10.1016/j.neuroimage.2018.08.073 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Fischl B. FreeSurfer. NeuroImage. 2012;62:774–781. 10.1016/j.neuroimage.2012.01.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Desikan RS, Ségonne F, Fischl B, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage. 2006;31:968–980. 10.1016/j.neuroimage.2006.01.021 [DOI] [PubMed] [Google Scholar]
- 53. Fortin JP, Cullen N, Sheline YI, et al. Harmonization of cortical thickness measurements across scanners and sites. NeuroImage. 2018;167:104–120. 10.1016/j.neuroimage.2017.11.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Vollmar C, O'Muircheartaigh J, Barker GJ, et al. Identical, but not the same: intra-site and inter-site reproducibility of fractional anisotropy measures on two 3.0T scanners. NeuroImage. 2010;51:1384–1394. 10.1016/j.neuroimage.2010.03.046 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Koo BB, Hua N, Choi CH, Ronen I, Lee JM, Kim DS. A framework to analyze partial volume effect on gray matter mean diffusivity measurements. NeuroImage. 2009;44:136–144. 10.1016/j.neuroimage.2008.07.064 [DOI] [PubMed] [Google Scholar]
- 56. Baxi M, Cetin-Karayumak S, Papadimitriou G, et al. Investigating the contribution of cytoarchitecture to diffusion MRI measures in gray matter using histology. Front Neuroimaging. 2022;1:947526. 10.3389/fnimg.2022.947526 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Jones DK, Knösche TR, Turner R. White matter integrity, fiber count, and other fallacies: the do’s and don’ts of diffusion MRI. NeuroImage. 2013;73:239–254. 10.1016/j.neuroimage.2012.06.081 [DOI] [PubMed] [Google Scholar]
- 58. Malcolm JG, Shenton ME, Rathi Y. Filtered multitensor tractography. IEEE Trans Med Imaging. 2010;29:1664–1675. 10.1109/TMI.2010.2048121 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Reddy CP, Rathi Y. Joint multi-fiber NODDI parameter estimation and tractography using the unscented information filter. Front Neurosci. 2016;10:166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Farquharson S, Tournier JD, Calamante F, et al. White matter fiber tractography: why we need to move beyond DTI. J Neurosurg. 2013;118:1367–1377. 10.3171/2013.2.JNS121294 [DOI] [PubMed] [Google Scholar]
- 61. Vos SB, Viergever MA, Leemans A. Multi-fiber tractography visualizations for diffusion MRI data. PLoS One. 2013;8:e81453. 10.1371/journal.pone.0081453 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Liao R, Ning L, Chen Z, et al. Performance of unscented Kalman filter tractography in edema: analysis of the two-tensor model. NeuroImage Clin. 2017;15:819–831. 10.1016/j.nicl.2017.06.027 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Guevara P, Duclap D, Poupon C, et al. Automatic fiber bundle segmentation in massive tractography datasets using a multi-subject bundle atlas. NeuroImage. 2012;61:1083–1099. 10.1016/j.neuroimage.2012.02.071 [DOI] [PubMed] [Google Scholar]
- 64. Jin Y, Shi Y, Zhan L, et al. Automatic clustering of white matter fibers in brain diffusion MRI with an application to genetics. NeuroImage. 2014;100:75–90. 10.1016/j.neuroimage.2014.04.048 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Lefranc S, Roca P, Perrot M, et al. Groupwise connectivity-based parcellation of the whole human cortical surface using watershed-driven dimension reduction. Med Image Anal. 2016;30:11–29. 10.1016/j.media.2016.01.003 [DOI] [PubMed] [Google Scholar]
- 66. Wassermann D, Makris N, Rathi Y, et al. The white matter query language: a novel approach for describing human white matter anatomy. Brain Struct Func. 2016;221:4705–4721. 10.1007/s00429-015-1179-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Avants BB, Epstein CL, Grossman M, Gee JC. Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain. Med Image Anal. 2008;12:26–41. 10.1016/j.media.2007.06.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Di Biase MA, Pantelis C, Zalesky A. White matter pathology in schizophrenia. In: Kubicki M, Shenton ME (eds.), Neuroimaging in Schizophrenia, pp. 71–91. Springer Nature, 2020. [Google Scholar]
- 69. Amado I, Bourdel MC, Daban C, et al. Preattentional processes and disorganization in schizophrenia: influence of a 6-week risperidone treatment. Prog Neuro-Psychopharmacol Biol Psychiatry. 2009;33:1107–1112. 10.1016/j.pnpbp.2009.06.004 [DOI] [PubMed] [Google Scholar]
- 70. Sasabayashi D, Takayanagi Y, Takahashi T, et al. Increased brain gyrification and subsequent relapse in patients with first-episode schizophrenia. Front Psychiatry. 2022;13:937605. 10.3389/fpsyt.2022.937605 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Goldberg EM, Morrison SL. Schizophrenia and social class. Br J Psychiatry. 1963;109:785–802. 10.1192/bjp.109.463.785 [DOI] [PubMed] [Google Scholar]
- 72. White T, Andreasen NC, Nopoulos P, Magnotta V. Gyrification abnormalities in childhood- and adolescent-onset schizophrenia. Biol Psychiatry. 2003;54:418–426. 10.1016/S0006-3223(03)00065-9 [DOI] [PubMed] [Google Scholar]
- 73. Palaniyappan L, Crow TJ, Hough M, et al. Gyrification of Broca's region is anomalously lateralized at onset of schizophrenia in adolescence and regresses at 2 year follow-up. Schizophr Res. 2013;147:39–45. 10.1016/j.schres.2013.03.028 [DOI] [PubMed] [Google Scholar]
- 74. Pham TV, Sasabayashi D, Takahashi T, et al. Longitudinal changes in brain gyrification in schizophrenia spectrum disorders. Front Aging Neurosci. 2021;13:752575. 10.3389/fnagi.2021.752575 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. Palaniyappan L, Liddle PF. Aberrant cortical gyrification in schizophrenia: a surface-based morphometry study. J Psychiatry Neurosci. 2012;37:399–406. 10.1503/jpn.110119 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76. Guo S, Palaniyappan L, Liddle PF, Feng J. Dynamic cerebral reorganization in the pathophysiology of schizophrenia: a MRI-derived cortical thickness study. Psychol Med. 2016;46:2201–2214. 10.1017/S0033291716000994 [DOI] [PubMed] [Google Scholar]
- 77. Papini C, Palaniyappan L, Kroll J, Froudist-Walsh S, Murray RM, Nosarti C. Altered cortical gyrification in adults who were born very preterm and its associations with cognition and mental health. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020;5:640–650. 10.1016/j.bpsc.2020.01.006 [DOI] [PubMed] [Google Scholar]
- 78. Janssen J, Alemán-Gómez Y, Schnack H, et al. Cortical morphology of adolescents with bipolar disorder and with schizophrenia. Schizophr Res. 2014;158:91–99. 10.1016/j.schres.2014.06.040 [DOI] [PubMed] [Google Scholar]
- 79. Madeira N, Duarte JV, Martins R, Costa GN, Macedo A, Castelo-Branco M. Morphometry and gyrification in bipolar disorder and schizophrenia: a comparative MRI study. NeuroImage Clin. 2020;26:102220. 10.1016/j.nicl.2020.102220 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80. Fan Q, Palaniyappan L, Tan L, et al. Surface anatomical profile of the cerebral cortex in obsessive-compulsive disorder: a study of cortical thickness, folding and surface area. Psychol Med. 2013;43:1081–1091. 10.1017/S0033291712001845 [DOI] [PubMed] [Google Scholar]
- 81. Palaniyappan L, Liddle PF. Dissociable morphometric differences of the inferior parietal lobule in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2012;262:579–587. 10.1007/s00406-012-0314-y [DOI] [PubMed] [Google Scholar]
- 82. Csernansky JG, Gillespie SK, Dierker DL, et al. Symmetric abnormalities in sulcal patterning in schizophrenia. Neuroimage. 2008;43:440–446. 10.1016/j.neuroimage.2008.07.034 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83. Cachia A, Paillère-Martinot ML, Galinowski A, et al. Cortical folding abnormalities in schizophrenia patients with resistant auditory hallucinations. Neuroimage. 2008;39:927–935. 10.1016/j.neuroimage.2007.08.049 [DOI] [PubMed] [Google Scholar]
- 84. Kompus K, Westerhausen R, Hugdahl K. The “paradoxical” engagement of the primary auditory cortex in patients with auditory verbal hallucinations: a meta-analysis of functional neuroimaging studies. Neuropsychologia. 2011;49:3361–3369. 10.1016/j.neuropsychologia.2011.08.010 [DOI] [PubMed] [Google Scholar]
- 85. Fuentes-Claramonte P, Martin-Subero M, Salgado-Pineda P, et al. Brain imaging correlates of self- and other-reflection in schizophrenia. NeuroImage Clin. 2020;25:102134. 10.1016/j.nicl.2019.102134 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86. Novak G, Seeman MV. Dopamine, psychosis, and symptom fluctuation: a narrative review. Healthcare (Basel). 2022;10:1713. 10.3390/healthcare10091713 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87. Jenner JA, Van de Willige G. The Auditory Vocal Hallucination Rating Scale (AVHRS). Groningen: University Center for Psychiatry, University Medical Center Groningen, University of Groningen, 2002. [Google Scholar]
- 88. Kirkpatrick B, Buchanan RW, Ross DE, Carpenter WT Jr. A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry. 2001;58:165–171. 10.1001/archpsyc.58.2.165 [DOI] [PubMed] [Google Scholar]
- 89. Garey LJ, Ong WY, Patel TS, et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry. 1998;65:446–453. 10.1136/jnnp.65.4.446 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90. Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry. 1998;55:215–224. 10.1001/archpsyc.55.3.215 [DOI] [PubMed] [Google Scholar]
- 91. Sweet RA, Pierri JN, Auh S, Sampson AR, Lewis DA. Reduced pyramidal cell somal volume in auditory association cortex of subjects with schizophrenia. Neuropsychopharmacology. 2003;28:599–609. 10.1038/sj.npp.1300120 [DOI] [PubMed] [Google Scholar]
- 92. Arion D, Huo Z, Enwright JF, Corradi JP, Tseng G, Lewis DA. Transcriptome alterations in prefrontal pyramidal cells distinguish schizophrenia from bipolar and major depressive disorders. Biol Psychiatry. 2017;82:594–600. 10.1016/j.biopsych.2017.03.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93. Kubicki M, Shenton ME, Maciejewski PK, et al. Decreased axial diffusivity within language connections: a possible biomarker of schizophrenia risk. Schizophr Res. 2013;148:67–73. 10.1016/j.schres.2013.06.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94. Østby Y, Tamnes CK, Fjell AM, Walhovd KB. Morphometry and connectivity of the fronto-parietal verbal working memory network in development. Neuropsychologia. 2011;49:3854–3862. 10.1016/j.neuropsychologia.2011.10.001 [DOI] [PubMed] [Google Scholar]
- 95. Becker Y, Loh KK, Coulon O, Meguerditchian A. The arcuate fasciculus and language origins: disentangling existing conceptions that influence evolutionary accounts. Neurosci Biobehav Rev. 2022;134:104490. 10.1016/j.neubiorev.2021.12.013 [DOI] [PubMed] [Google Scholar]
- 96. Lodato S, Arlotta P. Generating neuronal diversity in the mammalian cerebral cortex. Annu Rev Cell Dev Biol. 2015;31:699–720. 10.1146/annurev-cellbio-100814-125353 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97. Kubicki M, McCarley R, Westin CF, et al. A review of diffusion tensor imaging studies in schizophrenia. J Psychiatr Res. 2007;41:15–30. 10.1016/j.jpsychires.2005.05.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98. Ellison-Wright I, Bullmore E. Meta-analysis of diffusion tensor imaging studies in schizophrenia. Schizophr Res. 2009;108:3–10. 10.1016/j.schres.2008.11.021 [DOI] [PubMed] [Google Scholar]
- 99. Gao X, Yao L, Li F, et al. The cortical hypogyrification pattern in antipsychotic-naive first-episode schizophrenia. Cereb Cortex. 2023;33:7619–7626. 10.1093/cercor/bhad065 [DOI] [PubMed] [Google Scholar]
- 100. Li T, Wang Q, Zhang J, et al. Brain-wide analysis of functional connectivity in first-episode and chronic stages of schizophrenia. Schizophr Bull. 2017;43:436–448. 10.1093/schbul/sbw099 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101. Friston KJ. The disconnection hypothesis. Schizophr Res. 1998;30:115–125. 10.1016/S0920-9964(97)00140-0 [DOI] [PubMed] [Google Scholar]
- 102. Crow TJ. The two-syndrome concept: origins and current status. Schizophr Bull. 1985;11:471–488. 10.1093/schbul/11.3.471 [DOI] [PubMed] [Google Scholar]
- 103. Hovington CL, Bodnar M, Chakravarty MM, Joober R, Malla AK, Lepage M. Investigation of white matter abnormalities in first episode psychosis patients with persistent negative symptoms. Psychiatry Res. 2015;233:402–408. 10.1016/j.pscychresns.2015.06.017 [DOI] [PubMed] [Google Scholar]
- 104. Abram SV, Wisner KM, Fox JM, et al. Fronto-temporal connectivity predicts cognitive empathy deficits and experiential negative symptoms in schizophrenia. Hum Brain Mapp. 2017;38:1111–1124. 10.1002/hbm.23439 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105. Stanford AD, Sharif Z, Corcoran C, Urban N, Malaspina D, Lisanby SH. rTMS strategies for the study and treatment of schizophrenia: a review. Int J Neuropsychopharmacol. 2008;11:563–576. 10.1017/S1461145707008309 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106. Chang CC, Kao YC, Chao CY, Chang HA. Enhancement of cognitive insight and higher-order neurocognitive function by fronto-temporal transcranial direct current stimulation (tDCS) in patients with schizophrenia. Schizophr Res. 2019;208:430–438. 10.1016/j.schres.2018.12.052 [DOI] [PubMed] [Google Scholar]
- 107. Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry. 2011;68:128–137. 10.1001/archgenpsychiatry.2010.199 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108. Sasabayashi D, Takayanagi Y, Takahashi T, et al. Increased brain gyrification in the schizophrenia spectrum. Psychiatry Clin Neurosci. 2020;74:70–76. 10.1111/pcn.12939 [DOI] [PubMed] [Google Scholar]
- 109. Seitz-Holland J, Rathi Y, Lyall A, et al. Alteration of gray matter microstructure in schizophrenia. Brain Imaging Behav. 2018;12:54–63. 10.1007/s11682-016-9666-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110. Wang Q, Cheung C, Deng W, et al. White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment. Psychol Med. 2013;43:2301–2309. 10.1017/S0033291713000238 [DOI] [PubMed] [Google Scholar]
- 111. Van Dyken PC, MacKinley M, Khan AR, Palaniyappan L. Cortical network disruption is minimal in early stages of psychosis. Schizophr Bull Open. 2024;5:sgae010. 10.1093/schizbullopen/sgae010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112. Van Dyken PC, Yang K, Faria AV, et al. Stable white matter structure in the first three years after psychosis onset. Biol Psychiatry Glob Open Sci. 2025;5:100472. 10.1016/j.bpsgos.2025.100472 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113. Van Dyken PC, Khan AR, Palaniyappan L. Neurite density and kurtosis in the gray matter of people with early schizophrenia. Biol Psychiatry Cogn Neurosci Neuroimaging. in press [DOI] [PubMed] [Google Scholar]
- 114. Klauser P, Baker ST, Cropley VL, et al. White matter disruptions in schizophrenia are spatially widespread and topologically converge on brain network hubs. Schizophr Bull. 2017;43:425–435. 10.1093/schbul/sbw100 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115. Palaniyappan L, Marques TR, Taylor H, et al. Globally efficient brain organization and treatment response in psychosis: a connectomic study of gyrification. Schizophr Bull. 2016;42:1446–1456. 10.1093/schbul/sbw069 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116. Sasabayashi D, Tsugawa S, Nakajima S, et al. Increased structural covariance of cortical measures in individuals with an at-risk mental state. Prog Neuro-Psychopharmacol Biol Psychiatry. 2025;136:111197. 10.1016/j.pnpbp.2024.111197 [DOI] [PubMed] [Google Scholar]
- 117. Prasad KM, Muldoon B, Theis N, Iyengar S, Keshavan MS. Multipronged investigation of morphometry and connectivity of hippocampal network in relation to risk for psychosis using ultrahigh field MRI. Schizophr Res. 2023;256:88–97. 10.1016/j.schres.2023.05.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118. Takahashi T, Suzuki M. Brain morphologic changes in early stages of psychosis: implications for clinical application and early intervention. Psychiatry Clin Neurosci. 2018;72:556–571. 10.1111/pcn.12670 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The datasets generated and analyzed during the current study are not publicly available due to reasons of data privacy and regulatory/ethical approvals, but aggregate-level data are available from the corresponding author upon reasonable request and pending local and national data protection and ethics regulations.

